SCHEMBL7981485

SCHEMBL7981485

Fc1ccc(-c2cccc3c(Nc4cccc(-c5ncc[nH]5)c4)nccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 8/20 0.41
KDR P35968 4/20 0.39
MET P08581 2/20 0.39
PIM1 P11309 2/20 0.39
PIM2 Q9P1W9 2/20 0.39
VCP P55072 1/20 0.39
CASP6 P55212 1/20 0.39
CCR3 P51677 1/20 0.38
BRAF P15056 1/20 0.37
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7980998 0.91 VCP (0.47) ABCG2KDRMETPIM1PIM2
SCHEMBL7981286 0.81 MTOR (0.48) ABCG2KDRMETVCPCYP1A2
SCHEMBL7125034 0.75 RIPK2 (0.42) ABCG2BRAFMEN1LMNACYP1A2
SCHEMBL7119901 0.72 ABCG2 (0.47) ABCG2MEN1LMNAMAPTHPGD
SCHEMBL7122153 0.72 ABL1 (0.48) ABCG2PIM1PIM2BRAFLMNA
SCHEMBL7127026 0.71 AHR (0.53) ABCG2KDRBRAFMEN1LMNA
SCHEMBL7967916 0.70 KDR (0.48) KDRVCPBRAFLMNACYP1A2
SCHEMBL2049365 0.68 NISCH (0.52) CASP6MEN1KMT2AMTORADK
SCHEMBL1688521 0.68 NISCH (0.60) PIM1VCPMEN1CYP1A2CYP3A4
SCHEMBL771236 0.68 NISCH (0.64) MEN1CYP1A2CYP3A4CYP2D6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001087845-A2 N-CONTAINING HETEROCYCLIC COMPOUNDS AND THEIR USE AS 5-HT ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-22 WO disclosed